Key result
Implantable cardioverter defibrillators prevent sudden death in Brugada syndrome, while epicardial ablation is an emerging therapy that may offer a cure.
Why the study?
Proper clinical suspicion, ECG interpretation, and risk stratification are needed to diagnose and manage Brugada syndrome to prevent ventricular fibrillation, cardiac arrest, and sudden death.
This review summarizes the diagnostic approach, risk stratification, and management of Brugada syndrome, highlighting the potential of noninvasive ECG parameters and epicardial ablation.
May support ICDs for sudden death prevention in Brugada syndrome; leaves open epicardial ablation's curative role pending prospective data.
Brugada syndrome is a congenital channelopathy in cardiac ion transmembrane causing an alteration in the electrical conduction of the heart. ST-elevation, as well as right bundle-branch block in anterior precordial electrocardiography (ECG), is pathognomonic in this syndrome. The patient might be asymptomatic or with a history of syncope and prone to develop ventricular tachyarrhythmia which may spontaneously recover or degenerates to ventricular fibrillation, cardiac arrest and even sudden death. Nevertheless, this can be prevented by implantable cardioverter defibrillator implantation. Therefore, it is of paramount importance that clinical suspicion and identification, interpretation of its characteristic ECG pattern and risk stratification to be properly done to diagnose and to manage Brugada syndrome. The author has also done a systematic review (included in the article) for several noninvasive ECG parameters for risk stratification with promising results. Epicardial ablation is an emerging therapy that may “cure” Brugada syndrome.
No takes yet. Share an insight, caveat, or question.
Raymond Pranata (2019) conducted a review in Brugada syndrome. Diagnostic approach, risk stratification, and management was evaluated. Implantable cardioverter defibrillators prevent sudden death in Brugada syndrome, while epicardial ablation is an emerging therapy that may offer a cure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: